132 related articles for article (PubMed ID: 17597020)
1. STAT3, HIF-1alpha, EPO and EPOR - signaling proteins in human primary ductal breast cancers.
Wincewicz A; Sulkowska M; Koda M; Leśniewicz T; Kanczuga-Koda L; Sulkowski S
Folia Histochem Cytobiol; 2007; 45(2):81-6. PubMed ID: 17597020
[TBL] [Abstract][Full Text] [Related]
2. STAT3 and hypoxia induced proteins--HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancers.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Wincewicz D; Sulkowski S
Folia Histochem Cytobiol; 2009 Jan; 47(3):425-30. PubMed ID: 20164027
[TBL] [Abstract][Full Text] [Related]
3. The relationships between hypoxia-dependent markers: HIF-1alpha, EPO and EPOR in colorectal cancer.
Baltaziak M; Wincewicz A; Kanczuga-Koda L; Lotowska JM; Koda M; Sulkowska U; Baltaziak M; Podbielski M; Sobaniec-Lotowska ME; Sulkowski S
Folia Histochem Cytobiol; 2013; 51(4):320-5. PubMed ID: 24497137
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
6. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
Badowska-Kozakiewicz A; Sobol M; Patera J
Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
8. EPO improves the proliferation and inhibits apoptosis of trophoblast and decidual stromal cells through activating STAT-5 and inactivating p38 signal in human early pregnancy.
Ji YQ; Zhang YQ; Li MQ; Du MR; Wei WW; Li DJ
Int J Clin Exp Pathol; 2011; 4(8):765-74. PubMed ID: 22135724
[TBL] [Abstract][Full Text] [Related]
9. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of erythropoietin and its receptor expression in the rat carotid body during chronic and intermittent hypoxia.
Lam SY; Tipoe GL; Fung ML
Adv Exp Med Biol; 2009; 648():207-14. PubMed ID: 19536483
[TBL] [Abstract][Full Text] [Related]
11. HIF-1alpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart.
Maloyan A; Eli-Berchoer L; Semenza GL; Gerstenblith G; Stern MD; Horowitz M
Physiol Genomics; 2005 Sep; 23(1):79-88. PubMed ID: 16046617
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin and co.: intrinsic structure and functional disorder.
Uversky VN; Redwan EM
Mol Biosyst; 2016 Dec; 13(1):56-72. PubMed ID: 27833947
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma.
Diensthuber M; Potinius M; Rodt T; Stan AC; Welkoborsky HJ; Samii M; Schreyögg J; Lenarz T; Stöver T
J Neurooncol; 2008 Sep; 89(2):131-9. PubMed ID: 18431543
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancer.
Larsson AM; Jirström K; Fredlund E; Nilsson S; Rydén L; Landberg G; Påhlman S
Clin Cancer Res; 2009 Sep; 15(17):5552-9. PubMed ID: 19706814
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma.
Acs G; Zhang PJ; Rebbeck TR; Acs P; Verma A
Cancer; 2002 Sep; 95(5):969-81. PubMed ID: 12209679
[TBL] [Abstract][Full Text] [Related]
16. Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas.
Wincewicz A; Koda M; Sulkowska M; Kanczuga-Koda L; Sulkowski S
Tissue Cell; 2008 Dec; 40(6):405-10. PubMed ID: 18579174
[TBL] [Abstract][Full Text] [Related]
17. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of erythropoietin and its receptor in the developing midbrain.
Knabe W; Knerlich F; Washausen S; Kietzmann T; Sirén AL; Brunnett G; Kuhn HJ; Ehrenreich H
Anat Embryol (Berl); 2004 Mar; 207(6):503-12. PubMed ID: 14770308
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin is a hypoxia inducible factor-induced protective molecule in experimental autoimmune neuritis.
Luo B; Jiang M; Yang X; Zhang Z; Xiong J; Schluesener HJ; Zhang Z; Wu Y
Biochim Biophys Acta; 2013 Aug; 1832(8):1260-70. PubMed ID: 23603807
[TBL] [Abstract][Full Text] [Related]
20. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects.
García-Ramírez M; Hernández C; Simó R
Diabetes Care; 2008 Jun; 31(6):1189-94. PubMed ID: 18332162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
